LYNPARZA (olaparib) tablets. FDA-Approved

LYNPARZA (olaparib) tablets can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of LYNPARZA (olaparib) tablets to treat Ovarian cancer and Breast cancer.
Category: .

LYNPARZA (olaparib) tablets. FDA-Approved

What is FDA-approved LYNPARZA (olaparib) tablets indicated for?

LYNPARZA (olaparib) tablets is a prescription medicine. LYNPARZA (olaparib) tablets is used to treat Ovarian cancer and Breast cancer.
INDICATIONS AND USAGE
Lynparza is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated:
Ovarian cancer
• for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.
• for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer.
Breast cancer
• in patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
DOSAGE FORMS & STRENGTHS
Tablets: 150 mg, 100 mg
Manufactured By: AstraZeneca
Prescribing Information URL: Click Here

How to make an enquiry for LYNPARZA (olaparib) tablets?

Anticancer medicine LYNPARZA (olaparib) tablets available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Breast Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer.

What Olaparib is indicated for?

Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.

In December 2014, olaparib was approved for use as a single agent by the European Medicines Agency (EMA) in the European Union and by the Food and Drug Administration (FDA) in the United States. The FDA approval was for germline BRCA mutated (gBRCAm) advanced ovarian cancer that has received three or more prior lines of chemotherapy.[3] In January 2018, olaparib became the first PARP inhibitor to be approved by the FDA for gBRCAm metastatic breast cancer. Olaparib was developed and first dosed into patients by the UK-based biotechnology company, KuDOS Pharmaceuticals, that was founded by Stephen Jackson of Cambridge University, UK. Since KuDOS was acquired by AstraZeneca in 2006, the drug has undergone clinical development by AstraZeneca and Merck & Co. Olaparib in combination with temozolomide demonstrated substantial clinical activity in relapsed small cell lung cancer.

How and where to buy LYNPARZA (olaparib) tablets?

You can order LYNPARZA (olaparib) tablets from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer. To get best price/cost of LYNPARZA (olaparib) tablets in India, Call 8750295029 or Email urgent@medvitaz.com

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.